Challenges of continuation of live liver donor programme during COVID-19 pandemic in Pakistan: outcomes and lessons learned

Background COVID-19 pandemic has globally affected healthcare including the transplantation programmes.Materials and methods We retrospectively studied the impact of COVID-19 on live liver donor (LLD) programme at liver transplant centre in Gambat, Pakistan. Standard operative procedures (SOPs) incl...

Full description

Saved in:
Bibliographic Details
Main Authors: Azhar Hussain, Bilal Ahmed, Abdul Wahab Dogar, Shams Uddin, Syed Hasnain Abbas, Hala Izzo, Kaleem Ullah, Azam Shoaib, Siraj Ud Din, Muhammad Ameer Hamza, Munaza Zafar, Muhammad Affan Qaiser, Hamid Raza, Muhammad Asif Baig, Ali Husnain, Khalid Mumtaz
Format: Article
Language:English
Published: BMJ Publishing Group 2021-10-01
Series:BMJ Open Gastroenterology
Online Access:https://bmjopengastro.bmj.com/content/8/1/e000723.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846137977439256576
author Azhar Hussain
Bilal Ahmed
Abdul Wahab Dogar
Shams Uddin
Syed Hasnain Abbas
Hala Izzo
Kaleem Ullah
Azam Shoaib
Siraj Ud Din
Muhammad Ameer Hamza
Munaza Zafar
Muhammad Affan Qaiser
Hamid Raza
Muhammad Asif Baig
Ali Husnain
Khalid Mumtaz
author_facet Azhar Hussain
Bilal Ahmed
Abdul Wahab Dogar
Shams Uddin
Syed Hasnain Abbas
Hala Izzo
Kaleem Ullah
Azam Shoaib
Siraj Ud Din
Muhammad Ameer Hamza
Munaza Zafar
Muhammad Affan Qaiser
Hamid Raza
Muhammad Asif Baig
Ali Husnain
Khalid Mumtaz
author_sort Azhar Hussain
collection DOAJ
description Background COVID-19 pandemic has globally affected healthcare including the transplantation programmes.Materials and methods We retrospectively studied the impact of COVID-19 on live liver donor (LLD) programme at liver transplant centre in Gambat, Pakistan. Standard operative procedures (SOPs) including COVID-19 nasopharyngeal swab PCR, CT scans, personal protective equipment use, 6-feet distancing were developed for LLD and transplant team to mitigate COVID-19 exposure. We compared the complications, healthcare utilisation (hospital stay, readmission) and mortality between two LLD cohorts—before and during COVID-19 pandemic from March 2019 to December 2020.Results During study period 300 LLD surgeries were performed. There was an increase in rate of LLDs from 132 (44%) in pre-COVID to 168 (56%) during COVID-19 era. Average numbers of transplants per month performed during pre-COVID and during COVID-19 era were 10.1 and 14, respectively. No donor has developed COVID-19 infection during hospitalisation. Rate of all LLD complications (32 (21.47%) and 49 (29.16%), p=0.43), uneventful discharges (120/168 (71.4%) and 88/132 (66.6%), p<0.05), mean hospital stay (6±2 days and 5±2 days, p=0.17) and readmission (5 (4%) and 3 (1.8%), p=0.43) were similar during the pre-COVID and COVID-19 era. No donor mortality was observed during study period.Conclusion With the implementation of mindful SOPs, rate of LLD increased without any case of COVID-19 infection. Our SOPs were helpful in continuation of LLD programme in a developing country during COVID-19 pandemic.
format Article
id doaj-art-cf6d1569a4f444e996d1ed37d59b2c2d
institution Kabale University
issn 2054-4774
language English
publishDate 2021-10-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open Gastroenterology
spelling doaj-art-cf6d1569a4f444e996d1ed37d59b2c2d2024-12-07T16:55:16ZengBMJ Publishing GroupBMJ Open Gastroenterology2054-47742021-10-018110.1136/bmjgast-2021-000723Challenges of continuation of live liver donor programme during COVID-19 pandemic in Pakistan: outcomes and lessons learnedAzhar Hussain0Bilal Ahmed1Abdul Wahab Dogar2Shams Uddin3Syed Hasnain Abbas4Hala Izzo5Kaleem Ullah6Azam Shoaib7Siraj Ud Din8Muhammad Ameer Hamza9Munaza Zafar10Muhammad Affan Qaiser11Hamid Raza12Muhammad Asif Baig13Ali Husnain14Khalid Mumtaz15Ameer-ud-Din Medical College of PGMI, Lahore, PakistanLiver Transplant Unit, Gambat Institute of Medical Sciences, Gambat, PakistanDepartment of Liver Transplantation, Pir Abdul Qadir Shah Jeelani Institute of Medical Sciences, Gambat, PakistanLiver Transplant Unit, Gambat Institute of Medical Sciences, Gambat, PakistanLiver Transplant Unit, Gambat Institute of Medical Sciences, Gambat, PakistanLiver Transplant Unit, Gambat Institute of Medical Sciences, Gambat, PakistanDepartment of Liver Transplantation, Pir Abdul Qadir Shah Jeelani Institute of Medical Sciences, Gambat, PakistanDepartment of Liver Transplantation, Pir Abdul Qadir Shah Jeelani Institute of Medical Sciences, Gambat, PakistanLiver Transplant Unit, Gambat Institute of Medical Sciences, Gambat, PakistanLiver Transplant Unit, Gambat Institute of Medical Sciences, Gambat, PakistanLiver Transplant Unit, Gambat Institute of Medical Sciences, Gambat, PakistanLiver Transplant Unit, Gambat Institute of Medical Sciences, Gambat, PakistanLiver Transplant Unit, Gambat Institute of Medical Sciences, Gambat, PakistanLiver Transplant Unit, Gambat Institute of Medical Sciences, Gambat, PakistanLiver Transplant Unit, Gambat Institute of Medical Sciences, Gambat, PakistanOhio State University Foundation, Columbus, Ohio, USABackground COVID-19 pandemic has globally affected healthcare including the transplantation programmes.Materials and methods We retrospectively studied the impact of COVID-19 on live liver donor (LLD) programme at liver transplant centre in Gambat, Pakistan. Standard operative procedures (SOPs) including COVID-19 nasopharyngeal swab PCR, CT scans, personal protective equipment use, 6-feet distancing were developed for LLD and transplant team to mitigate COVID-19 exposure. We compared the complications, healthcare utilisation (hospital stay, readmission) and mortality between two LLD cohorts—before and during COVID-19 pandemic from March 2019 to December 2020.Results During study period 300 LLD surgeries were performed. There was an increase in rate of LLDs from 132 (44%) in pre-COVID to 168 (56%) during COVID-19 era. Average numbers of transplants per month performed during pre-COVID and during COVID-19 era were 10.1 and 14, respectively. No donor has developed COVID-19 infection during hospitalisation. Rate of all LLD complications (32 (21.47%) and 49 (29.16%), p=0.43), uneventful discharges (120/168 (71.4%) and 88/132 (66.6%), p<0.05), mean hospital stay (6±2 days and 5±2 days, p=0.17) and readmission (5 (4%) and 3 (1.8%), p=0.43) were similar during the pre-COVID and COVID-19 era. No donor mortality was observed during study period.Conclusion With the implementation of mindful SOPs, rate of LLD increased without any case of COVID-19 infection. Our SOPs were helpful in continuation of LLD programme in a developing country during COVID-19 pandemic.https://bmjopengastro.bmj.com/content/8/1/e000723.full
spellingShingle Azhar Hussain
Bilal Ahmed
Abdul Wahab Dogar
Shams Uddin
Syed Hasnain Abbas
Hala Izzo
Kaleem Ullah
Azam Shoaib
Siraj Ud Din
Muhammad Ameer Hamza
Munaza Zafar
Muhammad Affan Qaiser
Hamid Raza
Muhammad Asif Baig
Ali Husnain
Khalid Mumtaz
Challenges of continuation of live liver donor programme during COVID-19 pandemic in Pakistan: outcomes and lessons learned
BMJ Open Gastroenterology
title Challenges of continuation of live liver donor programme during COVID-19 pandemic in Pakistan: outcomes and lessons learned
title_full Challenges of continuation of live liver donor programme during COVID-19 pandemic in Pakistan: outcomes and lessons learned
title_fullStr Challenges of continuation of live liver donor programme during COVID-19 pandemic in Pakistan: outcomes and lessons learned
title_full_unstemmed Challenges of continuation of live liver donor programme during COVID-19 pandemic in Pakistan: outcomes and lessons learned
title_short Challenges of continuation of live liver donor programme during COVID-19 pandemic in Pakistan: outcomes and lessons learned
title_sort challenges of continuation of live liver donor programme during covid 19 pandemic in pakistan outcomes and lessons learned
url https://bmjopengastro.bmj.com/content/8/1/e000723.full
work_keys_str_mv AT azharhussain challengesofcontinuationofliveliverdonorprogrammeduringcovid19pandemicinpakistanoutcomesandlessonslearned
AT bilalahmed challengesofcontinuationofliveliverdonorprogrammeduringcovid19pandemicinpakistanoutcomesandlessonslearned
AT abdulwahabdogar challengesofcontinuationofliveliverdonorprogrammeduringcovid19pandemicinpakistanoutcomesandlessonslearned
AT shamsuddin challengesofcontinuationofliveliverdonorprogrammeduringcovid19pandemicinpakistanoutcomesandlessonslearned
AT syedhasnainabbas challengesofcontinuationofliveliverdonorprogrammeduringcovid19pandemicinpakistanoutcomesandlessonslearned
AT halaizzo challengesofcontinuationofliveliverdonorprogrammeduringcovid19pandemicinpakistanoutcomesandlessonslearned
AT kaleemullah challengesofcontinuationofliveliverdonorprogrammeduringcovid19pandemicinpakistanoutcomesandlessonslearned
AT azamshoaib challengesofcontinuationofliveliverdonorprogrammeduringcovid19pandemicinpakistanoutcomesandlessonslearned
AT sirajuddin challengesofcontinuationofliveliverdonorprogrammeduringcovid19pandemicinpakistanoutcomesandlessonslearned
AT muhammadameerhamza challengesofcontinuationofliveliverdonorprogrammeduringcovid19pandemicinpakistanoutcomesandlessonslearned
AT munazazafar challengesofcontinuationofliveliverdonorprogrammeduringcovid19pandemicinpakistanoutcomesandlessonslearned
AT muhammadaffanqaiser challengesofcontinuationofliveliverdonorprogrammeduringcovid19pandemicinpakistanoutcomesandlessonslearned
AT hamidraza challengesofcontinuationofliveliverdonorprogrammeduringcovid19pandemicinpakistanoutcomesandlessonslearned
AT muhammadasifbaig challengesofcontinuationofliveliverdonorprogrammeduringcovid19pandemicinpakistanoutcomesandlessonslearned
AT alihusnain challengesofcontinuationofliveliverdonorprogrammeduringcovid19pandemicinpakistanoutcomesandlessonslearned
AT khalidmumtaz challengesofcontinuationofliveliverdonorprogrammeduringcovid19pandemicinpakistanoutcomesandlessonslearned